Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Not yet recruiting × Primary Myelofibrosis × Clear all

Phase

Phase 1 4 Phase NA 2 Phase 2 1

Status

Completed 73 Terminated 24 Recruiting 13 Active not recruiting 11 Withdrawn 4 Unknown 2 Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Carcinoma, Non-Small-Cell Lung 112 Breast Neoplasms 81 Colorectal Neoplasms 52 Carcinoma, Hepatocellular 48 Stomach Neoplasms 43 Lung Neoplasms 40 Prostatic Neoplasms 39 Squamous Cell Carcinoma of Head and Neck 38 Triple Negative Breast Neoplasms 37 Small Cell Lung Carcinoma 37 Uterine Cervical Neoplasms 32 Rectal Neoplasms 32 Recurrence 27 Pancreatic Neoplasms 27 Leukemia, Myeloid, Acute 27 Neoplasms 26 Neoplasm Metastasis 25 Esophageal Squamous Cell Carcinoma 23 Ovarian Neoplasms 21 Brain Neoplasms 21 Nasopharyngeal Carcinoma 19 Esophageal Neoplasms 19 Multiple Myeloma 18 Glioblastoma 16 Colonic Neoplasms 16 Carcinoma, Renal Cell 16 Biliary Tract Neoplasms 16 Lymphoma, Large B-Cell, Diffuse 15 Endometrial Neoplasms 15 Head and Neck Neoplasms 14

Interventions

11-(2-pyrrolidin-1-ylethoxy)-14,19-dioxa-5,7,26-triazatetracyclo(19.3.1.1(2,6).1(8,12))heptacosa-1(25),2(26),3,5,8,10,12(27),16,21,23-decaene 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07394153 2026-02-06

PACRIMYEL

Grupo Español de Enfermedades Mieloproliferativas Crónicas PH Negativas

Phase 2 Not yet recruiting

Primary Myelofibrosis

Data powered by HemOnc (CC BY 4.0) Colophon ⚡